Prime Video is included in an Amazon Prime membership, and for new customers to Amazon the good news is that their 30-day free trial will last the entirety for the tournament – from Australia's ...

Australia rode on Josh Inglis' unbeaten century to beat England by five wickets to record the highest successful chase ever in any ICC 50-overs event, during their Champions Trophy match in Lahore ...

Add articles to your saved list and come back to them any time. Australia beat England by five wickets in a high-scoring Champions Trophy Group B match at the Gaddafi Stadium, Lahore in the early ...

However, the Vaccines segment experienced a 12% decline in sales, largely due to reduced demand for the RSV vaccine Arexvy. GSK has announced a £2 billion share buyback program over the next 18 ...

following a mandatory swine flu vaccine, Guillain-Barré is also an unexpectedly common adverse event from adenovirus-based COVID vaccines and has cropped up in trials for Pfizer’s Abrysvo and GSK’s ...

After predicting growth in vaccine sales in July of last year, poor performance from GSK’s Respiratory Syncytial Virus vaccine Arexvy led to an overall 4 percent drop in vaccine sales.

GSK’s Arexvy, which became the first RSV vaccine approved in 2023 and protects older adults, reached about $734 million in sales in 2024, down 52% from the previous year, according to the ...

By May 2024, the FDA approved three RSV vaccines for adults. The three FDA-approved RSV vaccines for adults 60 and older are GSK’s AREXVY, Pfizer’s ABRYSVO and Moderna’s mRESVIA. Initially, in June ...

Never has there been a greater need for Australia to end its military alliance with the United States and forge an independent and peaceful foreign policy. This would necessarily mean an alternative ...

The Moderna vaccine faces stiff competition from RSV vaccines Arexvy and Abrysvo, marketed by GSK and Pfizer, respectively. In the past year, MRNA stock has lost nearly 63%, significantly underper ...

So, the main culprit in GSK's revenue decline was Arexvy, whose sales in the U.S. fell sharply year-on-year, mainly due to increased competition from Pfizer's Abrysvo (PFE), as well as updated ...

The two main leaders of Tigray, who also are political rivals, urged the AU to pay attention to the implementation of the agreement. The AU-brokered agreement, reached in November 2022 ...